ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

LONDON, United-Kingdom, May 26, 2015/ — ViiV Healthcare (http://www.viivhealthcare.com), Aurobindo Pharma (http://www.aurobindo.com), and the Clinton Health Access Initiative, Inc. (CHAI) (http://www.clintonhealthaccess.org) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval,… Read More ›